Participant Characteristics from a 20-Day Peppermint Oil Hypertension Trial

40 individuals with pre- and stage 1 hypertension participated in a 20-day randomized, placebo-controlled trial (NCT05561543) exploring peppermint oil supplementation. The dataset, authored by Jonathan Sinclair and last updated in April 2026, contains participant characteristics and likely includes baseline and post-intervention measurements for blood pressure and other indices.

Use Cases

• Analyzing baseline characteristics of participants with pre-hypertension based on the trial population description
• Comparing systolic blood pressure changes between intervention and placebo groups based on the primary outcome mentioned
• Investigating secondary health outcomes like psychological wellbeing or sleep efficacy based on the description of secondary measurements
• Assessing trial compliance and adverse event rates based on the reported statistics

Strengths

• Data originates from a registered, parallel randomized controlled trial (NCT05561543), suggesting a structured study design
• Statistical results for the primary outcome are provided, including a significant adjusted mean difference of -8.48 mmHg
• Compliance was reported as very high (93.3%) in the intervention arm
• The dataset is openly licensed under CC-BY-4.0 for reuse

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• The dataset is very small (9.5 KB), indicating limited scope and likely a small number of variables

Provenance

Source

figshare, authored by Jonathan Sinclair

Collection Method

Collected from a 20-day parallel randomized, placebo-controlled clinical trial

Time Range

Trial duration was 20 days; specific collection dates are not provided

Freshness

Last updated 2026-04 23 17:23:41; freshness should be verified

Geography

Geographic coverage of participants is not specified